Skip to content
PubMed This is a summary of 21 peer-reviewed journal articles Updated
Cardiology

Building Your Care Team and Preparing for Appointments

At a Glance

People with nonobstructive coronary artery disease should seek a team experienced with INOCA or MINOCA, bring original imaging and complete test records to appointments, and report any new or different chest pain clearly because a prior clear angiogram does not rule out an emergency.

Navigating the healthcare system with a “non-obstructive” diagnosis can be one of the most challenging parts of your journey. Because many doctors are still trained to look only for major blockages, you may encounter clinicians who dismiss your symptoms once the angiogram is clear [1]. Finding a team that treats MINOCA and INOCA as “working diagnoses” rather than dead ends is essential for your recovery and long-term health [2][3].

Identifying a Specialized Heart Center

A high-quality heart center should follow a structured, mechanism-seeking pathway. This means they don’t stop at anatomy; they investigate how your heart functions [4][5].

When looking for a specialist—often found at large academic hospitals or Women’s Heart Centers—look for these hallmarks of excellence:

  • Comprehensive Testing Options: The ability to perform and interpret complex tests like Coronary Flow Reserve (CFR), Index of Microcirculatory Resistance (IMR), and acetylcholine provocation, or non-invasive equivalents [6][7].
  • Advanced Imaging Access: A team that integrates Cardiac MRI (CMR) and high-resolution “inside” views like OCT or IVUS to find tiny tears or plaque ruptures selectively [8][9].
  • Endotype-Guided Care: A commitment to tailoring your medications to your specific subtype (e.g., vasospasm vs. microvascular disease) rather than prescribing a “standard” heart regimen [10][11].
  • Multidisciplinary Support: Access to a team that includes interventional cardiologists, imaging experts, specialized pharmacists, and cardiac rehabilitation professionals [12][13].

Preparing Your Second-Opinion Packet

If you are seeking a second opinion, providing your new team with a “complete” picture is critical. Do not rely on your previous hospital to send over a simple summary. You should secure the following original files:

  1. Imaging Discs (DICOM Files): Request the actual moving images from your coronary angiogram and Cardiac MRI, not just the printed screenshots or written reports [14][15].
  2. Specific Reports: Ensure you have the full reports for your catheterization (including any CFR/IMR values), echocardiograms, and stress tests [14][3].
  3. Laboratory Trends: A record of your troponin levels and other cardiac blood tests during your event. Troponin is a blood protein released when heart muscle is injured, interpreted alongside symptoms and ECGs to evaluate a heart attack [14].
  4. Treatment History: A clear list of every heart medication you have tried, the dose, and whether it helped or caused side effects [16].

Advocacy in the Emergency Room

One of the most vulnerable moments for an INOCA/MINOCA patient is returning to the ER with new chest pain. Too often, doctors see a previous “clear” angiogram in your file and assume your pain is low-risk [17][18].

Strategies for being taken seriously in the ER:

  • State Your Symptoms First: State your current symptom onset, severity, associated symptoms, and medication list first, and explicitly say what is new or different.
  • State Your Diagnosis Clearly: Say “I have a diagnosis of INOCA (or MINOCA) and am being treated for coronary vasomotor dysfunction[19]. However, do not use your diagnosis to shut down the evaluation; emergency clinicians should evaluate the current episode with an ECG, serial troponin, and other tests as indicated, regardless of a prior non-obstructive angiogram [20].
  • The One-Page Summary: Carry a one-page document from your specialist that lists your specific diagnosis, your previous test results, your current medicines, and a direct phone number for your cardiologist [12]. The diagnosis card is a communication aid, not a substitute for standard emergency evaluation.
  • Describe “New” or “Different”: Be specific about how your current symptoms differ from your daily “baseline” pain. This helps the ER team prioritize an acute evaluation [21].

Your role as an advocate is to ensure that your medical history—not just a “normal” X-ray—is what drives your care. By building a specialized team and preparing your documentation, you move from a place of uncertainty to a position of informed power.

Common questions in this guide

How do I find a specialist for nonobstructive coronary artery disease?
Look for a cardiology team at an academic hospital or specialized Women’s Heart Center that treats INOCA and MINOCA as real working diagnoses. Ask whether the team can assess coronary blood flow and artery function, use advanced imaging when appropriate, and tailor treatment to the suspected cause.
What should I bring to a second-opinion appointment for INOCA?
Bring the original moving image files from your angiogram and cardiac MRI, full reports from your catheterization, echocardiograms, and stress tests, blood-test trends such as troponin, and a list of every heart medicine, dose, benefit, and side effect. Troponin is a blood marker of heart-muscle injury, and original image files are more useful for review than printed screenshots alone.
What should I tell the ER if I have new chest pain after a clear angiogram?
Tell the team when the symptoms began, how severe they are, what feels new or different, any associated symptoms, and which medicines you take. Explain that you have INOCA or MINOCA, but a prior nonobstructive angiogram does not rule out a new emergency; clinicians should decide whether you need an ECG, repeat troponin tests, and other evaluation.
Can I have heart-related chest pain if my angiogram showed no major blockage?
Yes. An angiogram can show no major blockage even when coronary artery spasm or problems in the heart’s small blood vessels affect blood flow and cause symptoms. Additional testing may be needed to identify the mechanism and guide treatment.
What should I ask a heart center about its INOCA testing experience?
Ask how often the center performs coronary function testing and whether it uses adenosine and acetylcholine to assess blood flow and artery spasm. You can also ask whether cardiology, imaging, pharmacy, and cardiac rehabilitation professionals work together and whether the center will provide a written emergency plan.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How many invasive coronary function tests (CFTs) do you perform annually, and do you use both adenosine and acetylcholine provocation?
  2. 2.If my diagnostic tests were 'inconclusive' at another hospital, what is your specific protocol for finding the underlying mechanism of my pain?
  3. 3.Do you work with a multidisciplinary team that includes specialists in cardiac MRI, microvascular disease, and women's heart health?
  4. 4.What is your center's diagnostic yield for MINOCA—how often do you find a specific cause after a clear angiogram?
  5. 5.Will you provide a written 'emergency protocol' that I can give to ER doctors if I have another acute event?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (21)
  1. 1

    The role of coronary reactivity testing in women with no obstructive coronary artery disease.

    AlBadri A, Mavromatis K, Bairey Merz CN

    Current opinion in cardiology 2019; (34(6)):656-662 doi:10.1097/HCO.0000000000000682.

    PMID: 31490202
  2. 2

    Myocardial infarction with non-obstructive coronary arteries (MINOCA).

    Yildiz M, Ashokprabhu N, Shewale A, et al.

    Frontiers in cardiovascular medicine 2022; (9()):1032436 doi:10.3389/fcvm.2022.1032436.

    PMID: 36457805
  3. 3

    MINOCA (Myocardial Infarction With Non-obstructive Coronary Arteries) Due to Diffuse Coronary Microvascular Dysfunction in a Patient With Systemic Autoimmune Disease and Chronic Kidney Disease.

    Kamboj T, Gill SS, Chopra N, Wander GS

    Cureus 2026; (18(2)):e103816 doi:10.7759/cureus.103816.

    PMID: 41869121
  4. 4

    Myocardial Infarction with Nonobstructive Coronary Arteries.

    Reynolds HR, Smilowitz NR

    Annual review of medicine 2023; (74()):171-188 doi:10.1146/annurev-med-042921-111727.

    PMID: 36179347
  5. 5

    Canadian Cardiovascular Society/Canadian Women's Heart Health Alliance Clinical Practice Update on Myocardial Infarction With No Obstructive Coronary Artery Disease (MINOCA).

    Pacheco C, Coutinho T, Bastiany A, et al.

    The Canadian journal of cardiology 2024; (40(6)):953-968 doi:10.1016/j.cjca.2024.02.032.

    PMID: 38852985
  6. 6

    Safety and prognostic relevance of acetylcholine testing in patients with stable myocardial ischaemia or myocardial infarction and non-obstructive coronary arteries.

    Montone RA, Rinaldi R, Del Buono MG, et al.

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2022; (18(8)):e666-e676 doi:10.4244/EIJ-D-21-00971.

    PMID: 35377315
  7. 7

    Diagnostic Advancements in MINOCA: Do They Translate to a Better Clinical Outcome? A Review of the Literature.

    Bozika M, Apostolos A, Nastouli KM, et al.

    Medicina (Kaunas, Lithuania) 2026; (62(7)) doi:10.3390/medicina62071243.

    PMID: 42512786
  8. 8

    Diagnostic Value of Cardiac Magnetic Resonance Imaging and Intracoronary Optical Coherence Tomography in Patients With a Working Diagnosis of Myocardial Infarction With Non-obstructive Coronary Arteries - A Systematic Review and Meta-analysis.

    Machanahalli Balakrishna A, Ismayl M, Thandra A, et al.

    Current problems in cardiology 2023; (48(6)):101126 doi:10.1016/j.cpcardiol.2022.101126.

    PMID: 35120967
  9. 9

    Pathological findings at invasive assessment in MINOCA: a systematic review and meta-analysis.

    Fedele D, Cavallo D, Bodega F, et al.

    Heart (British Cardiac Society) 2025; (111(7)):291-299 doi:10.1136/heartjnl-2024-324565.

    PMID: 39689931
  10. 10

    Functional coronary vascular disease: endotype-based classification, diagnosis, and targeted management.

    El Khatib O, Al Azzoni A, Shantouf R, Atallah B

    Frontiers in cardiovascular medicine 2026; (13()):1811419 doi:10.3389/fcvm.2026.1811419.

    PMID: 42548607
  11. 11

    Invasive Functional Coronary Assessment in Myocardial Ischemia with Non-Obstructive Coronary Arteries: from Pathophysiological Mechanisms to Clinical Implications.

    Rinaldi R, Salzillo C, Caffè A, Montone RA

    Reviews in cardiovascular medicine 2022; (23(11)):371 doi:10.31083/j.rcm2311371.

    PMID: 39076191
  12. 12

    The Imaging Toolbox to Assess Patients with Suspected Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease (MINOCA).

    Talebi S, Moreno P, Dominguez AC, Tamis-Holland JE

    Current cardiology reports 2020; (22(11)):134 doi:10.1007/s11886-020-01379-x.

    PMID: 32910364
  13. 13

    One-Year Prospective Follow-up of Women With INOCA and MINOCA at a Canadian Women's Heart Centre.

    Parvand M, Cai L, Ghadiri S, et al.

    The Canadian journal of cardiology 2022; (38(10)):1600-1610 doi:10.1016/j.cjca.2022.07.005.

    PMID: 36202592
  14. 14

    Editor's Choice- Pathophysiology, diagnosis and management of MINOCA: an update.

    Scalone G, Niccoli G, Crea F

    European heart journal. Acute cardiovascular care 2019; (8(1)):54-62 doi:10.1177/2048872618782414.

    PMID: 29952633
  15. 15

    Role of Cardiac Imaging in Myocardial Infarction With Non-Obstructive Coronary Arteries.

    Alonso AIB, Cabrero JB, Stojanovska J, et al.

    Echocardiography (Mount Kisco, N.Y.) 2025; (42(6)):e70198 doi:10.1111/echo.70198.

    PMID: 40444434
  16. 16

    Myocardial infarction with non-obstructive coronary arteries (MINOCA) in Chinese patients: Clinical features, treatment and 1 year follow-up.

    Abdu FA, Liu L, Mohammed AQ, et al.

    International journal of cardiology 2019; (287()):27-31 doi:10.1016/j.ijcard.2019.02.036.

    PMID: 30826195
  17. 17

    A Practical Approach to Invasive Testing in Ischemia With No Obstructive Coronary Arteries (INOCA).

    Bastiany A, Pacheco C, Sedlak T, et al.

    CJC open 2022; (4(8)):709-720 doi:10.1016/j.cjco.2022.04.009.

    PMID: 36035733
  18. 18

    Clinical presentation and 3-year outcomes of patients with acute coronary syndromes and non-obstructive coronary arteries on angiography.

    Zandecki L, Janion-Sadowska A, Kurzawski J, et al.

    PloS one 2020; (15(6)):e0234735 doi:10.1371/journal.pone.0234735.

    PMID: 32544195
  19. 19

    Diagnostic pathways in myocardial infarction with non-obstructive coronary artery disease (MINOCA).

    Occhipinti G, Bucciarelli-Ducci C, Capodanno D

    European heart journal. Acute cardiovascular care 2021; (10(7)):813-822 doi:10.1093/ehjacc/zuab049.

    PMID: 34179954
  20. 20

    Ischemia and no obstructive coronary arteries in patients with stable ischemic heart disease.

    Mehta PK, Quesada O, Al-Badri A, et al.

    International journal of cardiology 2022; (348()):1-8 doi:10.1016/j.ijcard.2021.12.013.

    PMID: 34902504
  21. 21

    Patient-Reported Symptoms of Acute Coronary Syndrome in the Prehospital Period in a Prospective Study: Implications for Emergency Nurse Triage, Diagnosis, and Clinical Outcomes.

    Zègre-Hemsey JK, Wong E, Crandell J, et al.

    Journal of emergency nursing 2025; (51(6)):1070-1083 doi:10.1016/j.jen.2025.04.016.

    PMID: 40455184

This page is for informational purposes only and does not constitute medical advice. It explains care planning for nonobstructive coronary artery disease, but your cardiologist or emergency team must guide decisions about your symptoms.

Get notified when new evidence is published on nonobstructive coronary artery disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.